Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Edward Murphy, MD, MPH

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentLaboratory Medicine
    Address270 Masonic
    San Francisco CA 94143

       ORNG Applications 
       Websites
       In The News
       NIH Awarded Grants
       Global Health
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Roubinian NH, Escobar GJ, Liu V, Swain BE, Gardner MN, Kipnis P, Triulzi DJ, Gottschall JL, Wu Y, Carson JL, Kleinman SH, Murphy EL. Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. Transfusion. 2014 Oct; 54(10 Pt 2):2678-86.
        View in: PubMed
      2. Roubinian NH, Escobar GJ, Liu V, Gardner MN, Carson JL, Kleinman SH, Murphy EL. Decreased red blood cell use and mortality in hospitalized patients. JAMA Intern Med. 2014 Aug 1; 174(8):1405-7.
        View in: PubMed
      3. Looney MR, Roubinian N, Gajic O, Gropper MA, Hubmayr RD, Lowell CA, Bacchetti P, Wilson G, Koenigsberg M, Lee DC, Wu P, Grimes B, Norris PJ, Murphy EL, Gandhi MJ, Winters JL, Mair DC, Schuller RM, Hirschler NV, Rosen RS, Matthay MA, Toy P. Prospective study on the clinical course and outcomes in transfusion-related acute lung injury*. Crit Care Med. 2014 Jul; 42(7):1676-87.
        View in: PubMed
      4. Roubinian NH, Murphy EL, Swain BE, Gardner MN, Liu V, Escobar GJ. Predicting red blood cell transfusion in hospitalized patients: role of hemoglobin level, comorbidities, and illness severity. BMC Health Serv Res. 2014; 14(1):213.
        View in: PubMed
      5. Melamed A, Witkover AD, Laydon DJ, Brown R, Ladell K, Miners K, Rowan AG, Gormley N, Price DA, Taylor GP, Murphy EL, Bangham CR. Clonality of HTLV-2 in Natural Infection. PLoS Pathog. 2014 Mar; 10(3):e1004006.
        View in: PubMed
      6. Loureiro P, de Almeida-Neto C, Proietti AB, Capuani L, Gonçalez TT, de Oliveira CD, Leão SC, Lopes MI, Sampaio D, Patavino GM, Ferreira JE, Blatyta PF, Lopes ME, Mendrone-Junior A, Salles NA, King M, Murphy E, Busch M, Custer B, Sabino EC. Contribution of the Retrovirus Epidemiology Donor Study (REDS) to research on blood transfusion safety in Brazil. Rev Bras Hematol Hemoter. 2014 Mar; 36(2):152-8.
        View in: PubMed
      7. Barbeau B, Hiscott J, Bazarbachi A, Carvalho E, Jones K, Martin F, Matsuoka M, Murphy EL, Ratner L, Switzer WM, Watanabe T. Conference highlights of the 16th international conference on human retrovirology: HTLV and related retroviruses, 26-30 june 2013, montreal, Canada. Retrovirology. 2014; 11(1):19.
        View in: PubMed
      8. Tagny CT, Mbanya D, Murphy EL, Lefrère JJ, Laperche S. Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test. J Virol Methods. 2014 Apr; 199:119-23.
        View in: PubMed
      9. Tagny CT, Murphy EL, Lefrère JJ. [The francophone Africa blood transfusion research network: A five-year report]. Transfus Clin Biol. 2014 Mar; 21(1):37-42.
        View in: PubMed
      10. Kleinman S, Busch MP, Murphy EL, Shan H, Ness P, Glynn SA. The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS-III): a research program striving to improve blood donor and transfusion recipient outcomes. Transfusion. 2014 Mar; 54(3 Pt 2):942-55.
        View in: PubMed
      11. Chang YB, Kaidarova Z, Hindes D, Bravo M, Kiely N, Kamel H, Dubay D, Hoose B, Murphy EL. Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009. J Infect Dis. 2014 Feb; 209(4):523-31.
        View in: PubMed
      12. Sabino EC, Ribeiro AL, Salemi VM, Ianni BM, Nastari L, Fernandes F, Di Lorenzo Oliveira C, Antunes AP, Menezes MM, Patavino GM, Capuani L, de Almeida-Neto C, Sachdev V, Carrick DM, Wright D, Kavounis K, Gonzalez TT, Custer B, Busch MP, Murphy EL, Carneiro-Proietti AB. Response to letters regarding article, "Ten-year incidence of Chagas cardiomyopathy among asymptomatic, Trypanosoma cruzi-seropositive former blood donors". Circulation. 2013 Aug 27; 128(9):e137-8.
        View in: PubMed
      13. Kiss JE, Steele WR, Wright DJ, Mast AE, Carey PM, Murphy EL, Gottschall JL, Simon TL, Cable RG. Laboratory variables for assessing iron deficiency in REDS-II Iron Status Evaluation (RISE) blood donors. Transfusion. 2013 Nov; 53(11):2766-75.
        View in: PubMed
      14. Sabino EC, Ribeiro AL, Salemi VM, Di Lorenzo Oliveira C, Antunes AP, Menezes MM, Ianni BM, Nastari L, Fernandes F, Patavino GM, Sachdev V, Capuani L, de Almeida-Neto C, Carrick DM, Wright D, Kavounis K, Goncalez TT, Carneiro-Proietti AB, Custer B, Busch MP, Murphy EL. Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors. Circulation. 2013 Mar 12; 127(10):1105-15.
        View in: PubMed
      15. Terrault NA, Dodge JL, Murphy EL, Tavis JE, Kiss A, Levin TR, Gish RG, Busch MP, Reingold AL, Alter MJ. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology. 2013 Mar; 57(3):881-9.
        View in: PubMed
      16. Murphy EL, Kwaan N, Looney MR, Gajic O, Hubmayr RD, Gropper MA, Koenigsberg M, Wilson G, Matthay M, Bacchetti P, Toy P. Risk factors and outcomes in transfusion-associated circulatory overload. Am J Med. 2013 Apr; 126(4):357.e29-38.
        View in: PubMed
      17. de Almeida-Neto C, Sabino EC, Liu J, Blatyta PF, Mendrone-Junior A, Salles NA, Leão SC, Wright DJ, Basques FV, Ferreira JE, Busch MP, Murphy EL. Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus. Transfusion. 2013 Apr; 53(4):827-34.
        View in: PubMed
      18. Murphy EL. The increasing burden of mortality from viral hepatitis in the United States. Ann Intern Med. 2012 Jul 17; 157(2):149-50; author reply 150.
        View in: PubMed
      19. Kouao MD, Dembelé B, N'Goran LK, Konaté S, Bloch E, Murphy EL, Lefrère JJ. Reasons for blood donation deferral in sub-Saharan Africa: experience in Ivory Coast. Transfusion. 2012 Jul; 52(7 Pt 2):1602-6.
        View in: PubMed
      20. Kleinman S, King MR, Busch MP, Murphy EL, Glynn SA. The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability. Transfus Med Rev. 2012 Oct; 26(4):281-304, 304.e1-2.
        View in: PubMed
      21. Carneiro-Proietti AB, Sabino EC, Leão S, Salles NA, Loureiro P, Sarr M, Wright D, Busch M, Proietti FA, Murphy EL. Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009. AIDS Res Hum Retroviruses. 2012 Oct; 28(10):1265-72.
        View in: PubMed
      22. Guiltinan AM, Kaidarova Z, Behan D, Marosi C, Hutching S, Kaiser M, Moore E, Devita D, Murphy EL. Major depression and generalized anxiety disorder among human T-lymphotropic virus types I- and II-infected former blood donors. Transfusion. 2013 Jan; 53(1):60-8.
        View in: PubMed
      23. van den Berg K, Lam J, Bruhn R, Custer B, Murphy EL. Water administration and the risk of syncope and presyncope during blood donation: a randomized clinical trial. Transfusion. 2012 Dec; 52(12):2577-84.
        View in: PubMed
      24. Mast AE, Steele WR, Johnson B, Wright DJ, Cable RG, Carey P, Gottschall JL, Kiss JE, Simon TL, Murphy EL. Population-based screening for anemia using first-time blood donors. Am J Hematol. 2012 May; 87(5):496-502.
        View in: PubMed
      25. Murphy EL, Schlumpf K, Wright DJ, Cable R, Roback J, Sacher R, Busch MP. BMI and obesity in US blood donors: a potential public health role for the blood centre. Public Health Nutr. 2012 Jun; 15(6):964-71.
        View in: PubMed
      26. Mast AE, Lee TH, Schlumpf KS, Wright DJ, Johnson B, Carrick DM, Cable RG, Kiss JE, Glynn SA, Steele WR, Murphy EL, Sacher R, Busch MP. The impact of HFE mutations on haemoglobin and iron status in individuals experiencing repeated iron loss through blood donation*. Br J Haematol. 2012 Feb; 156(3):388-401.
        View in: PubMed
      27. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, Lowell CA, Norris PJ, Murphy EL, Weiskopf RB, Wilson G, Koenigsberg M, Lee D, Schuller R, Wu P, Grimes B, Gandhi MJ, Winters JL, Mair D, Hirschler N, Sanchez Rosen R, Matthay MA. Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012 Feb 16; 119(7):1757-67.
        View in: PubMed
      28. Gonçalez TT, Sabino EC, Schlumpf KS, Wright DJ, Leao S, Sampaio D, Takecian PL, Proietti AB, Proitetti AB, Murphy E, Busch M, Custer B. Vasovagal reactions in whole blood donors at three REDS-II blood centers in Brazil. Transfusion. 2012 May; 52(5):1070-8.
        View in: PubMed
      29. Douceron E, Kaidarova Z, Miyazato P, Matsuoka M, Murphy EL, Mahieux R. HTLV-2 APH-2 expression is correlated with proviral load but APH-2 does not promote lymphocytosis. J Infect Dis. 2012 Jan 1; 205(1):82-6.
        View in: PubMed
      30. Martin F, Bangham CR, Ciminale V, Lairmore MD, Murphy EL, Switzer WM, Mahieux R. Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium. Retrovirology. 2011; 8:86.
        View in: PubMed
      31. Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL, Wright DJ, Sacher RA, Gottschall JL, Tobler LH, Simon TL. Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2012 Apr; 52(4):702-11.
        View in: PubMed
      32. Tagny CT, Kouao MD, Touré H, Gargouri J, Fazul AS, Ouattara S, Anani L, Othmani H, Feteke L, Dahourou H, Mbensa GO, Molé S, Nébié Y, Mbangue M, Toukam M, Boulahi MO, Andriambelo LV, Rakoto O, Baby M, Yahaya R, Bokilo A, Senyana F, Mbanya D, Shiboski C, Murphy EL, Lefrère JJ. Transfusion safety in francophone African countries: an analysis of strategies for the medical selection of blood donors. Transfusion. 2012 Jan; 52(1):134-43.
        View in: PubMed
      33. de Almeida Neto C, Mendrone A, Custer B, Liu J, Carneiro-Proietti AB, Leão SA, Wright DJ, Murphy EL, Sabino EC. Interdonation intervals and patterns of return among blood donors in Brazil. Transfusion. 2012 Apr; 52(4):722-8.
        View in: PubMed
      34. Bloch EM, Vermeulen M, Murphy E. Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges. Transfus Med Rev. 2012 Apr; 26(2):164-80.
        View in: PubMed
      35. Nébié K, Ouattara S, Sanou M, Kientega Y, Dahourou H, Ky L, Kienou K, Diallo S, Bigirimana F, Fretz C, Murphy EL, Lefrère JJ. Poor procedures and quality control among nonaffiliated blood centers in Burkina Faso: an argument for expanding the reach of the national blood transfusion center. Transfusion. 2011 Jul; 51(7 Pt 2):1613-8.
        View in: PubMed
      36. Kleinman SH, Triulzi DJ, Murphy EL, Carey PM, Gottschall JL, Roback JD, Carrick D, Mathew S, Wright DJ, Cable R, Ness P, Gajic O, Hubmayr RD, Looney MR, Kakaiya RM. The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components. Transfusion. 2011 Oct; 51(10):2078-91.
        View in: PubMed
      37. Bahrami SH, Guiltinan AM, Schlumpf KS, Scott E, Banks LL, D'Andrea P, Hartman EL, Vij V, Wright DJ, Spencer B, Murphy EL. Donation frequency of blood donors participating in a prospective cohort study of iron status. Transfusion. 2011 Jun; 51(6):1207-12.
        View in: PubMed
      38. Tagny CT, Mbanya D, Leballais L, Murphy E, Lefrère JJ, Laperche S. Reduction of the risk of transfusion-transmitted human immunodeficiency virus (HIV) infection by using an HIV antigen/antibody combination assay in blood donation screening in Cameroon. Transfusion. 2011 Jan; 51(1):184-90.
        View in: PubMed
      39. Rios JA, Schlumpf KS, Kakaiya RM, Triulzi DJ, Roback JD, Kleinman SH, Murphy EL, Gottschall JL, Carey PM. Blood donations from previously transfused or pregnant donors: a multicenter study to determine the frequency of alloexposure. Transfusion. 2011 Jun; 51(6):1197-206.
        View in: PubMed
      40. Lefrère JJ, Dahourouh H, Dokekias AE, Kouao MD, Diarra A, Diop S, Tapko JB, Murphy EL, Laperche S, Pillonel J. Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study. Transfusion. 2011 Mar; 51(3):486-92.
        View in: PubMed
      41. Rice MS, Custer BS, Hindes DA, Hirschler NV, Nguyen KA, Busch MP, Murphy EL. Genetic research in the blood bank: acceptability to Northern California donors. Transfusion. 2010 Sep; 50(9):1951-8.
        View in: PubMed
      42. Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL, Wright DJ, Sacher RA, Gottschall JL, Vij V, Simon TL. Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2011 Mar; 51(3):511-22.
        View in: PubMed
      43. Murphy EL, Fang J, Tu Y, Cable R, Hillyer CD, Sacher R, Triulzi D, Gottschall JL, Busch MP. Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index. J Infect Dis. 2010 Aug 15; 202(4):576-84.
        View in: PubMed
      44. Biswas HH, Kaidarova Z, Garratty G, Gibble JW, Newman BH, Smith JW, Ziman A, Fridey JL, Sacher RA, Murphy EL. Increased all-cause and cancer mortality in HTLV-II infection. J Acquir Immune Defic Syndr. 2010 Jul; 54(3):290-6.
        View in: PubMed
      45. Berini CA, Gendler SA, Pascuccio S, Eirin ME, McFarland W, Page K, Carnevali L, Murphy E, Biglione MM. Decreasing trends in HTLV-1/2 but stable HIV-1 infection among replacement donors in Argentina. J Med Virol. 2010 May; 82(5):873-7.
        View in: PubMed
      46. Goncalez T, Sabino E, Sales N, Chen YH, Chamone D, Busch M, Murphy E, Custer B, McFarland W. Human immunodeficiency virus test-seeking blood donors in a large blood bank in São Paulo, Brazil. Transfusion. 2010 Aug; 50(8):1806-14.
        View in: PubMed
      47. Mast AE, Schlumpf KS, Wright DJ, Custer B, Spencer B, Murphy EL, Simon TL. Demographic correlates of low hemoglobin deferral among prospective whole blood donors. Transfusion. 2010 Aug; 50(8):1794-802.
        View in: PubMed
      48. Tobler LH, Bahrami SH, Kaidarova Z, Pitina L, Winkelman VK, Vanderpool SK, Guiltinan AM, Cooper S, Busch MP, Murphy EL. A case-control study of factors associated with resolution of hepatitis C viremia in former blood donors (CME). Transfusion. 2010 Jul; 50(7):1513-23.
        View in: PubMed
      49. Edgren G, Kamper-Jørgensen M, Eloranta S, Rostgaard K, Custer B, Ullum H, Murphy EL, Busch MP, Reilly M, Melbye M, Hjalgrim H, Nyrén O. Duration of red blood cell storage and survival of transfused patients (CME). Transfusion. 2010 Jun; 50(6):1185-95.
        View in: PubMed
      50. Gordon SN, Weissman AR, Cecchinato V, Fenizia C, Ma ZM, Lee TH, Zaffiri L, Andresen V, Parks RW, Jones KS, Heraud JM, Ferrari MG, Chung HK, Venzon D, Mahieux R, Murphy EL, Jacobson S, Miller CJ, Ruscetti FW, Franchini G. Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques. J Virol. 2010 Mar; 84(6):3043-58.
        View in: PubMed
      51. Norris PJ, Hirschkorn DF, DeVita DA, Lee TH, Murphy EL. Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells. Virulence. 2010 Jan-Feb; 1(1):19-28.
        View in: PubMed
      52. Carneiro-Proietti AB, Sabino EC, Sampaio D, Proietti FA, Gonçalez TT, Oliveira CD, Ferreira JE, Liu J, Custer B, Schreiber GB, Murphy EL, Busch MP. Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS-II study, 2007 to 2008. Transfusion. 2010 Apr; 50(4):918-25.
        View in: PubMed
      53. Gonçalez TT, Sabino EC, Salles NA, de Almeida-Neto C, Mendrone-Jr A, Dorlhiac-Laccer PE, Liu J, Murphy EL, Schreiber GB. The impact of simple donor education on donor behavioral deferral and infectious disease rates in São Paulo, Brazil. Transfusion. 2010 Apr; 50(4):909-17.
        View in: PubMed
      54. Remesar MC, Gamba C, Colaianni IF, Puppo M, Sartor PA, Murphy EL, Neilands TB, Ridolfi MA, Leguizamón MS, Kuperman S, Del Pozo AE. Estimation of sensitivity and specificity of several Trypanosoma cruzi antibody assays in blood donors in Argentina. Transfusion. 2009 Nov; 49(11):2352-8.
        View in: PubMed
      55. Tagny CT, Diarra A, Yahaya R, Hakizimana M, Nguessan A, Mbensa G, Nébié Y, Dahourou H, Mbanya D, Shiboski C, Murphy E, Lefrère JJ. Characteristics of blood donors and donated blood in sub-Saharan Francophone Africa. Transfusion. 2009 Aug; 49(8):1592-9.
        View in: PubMed
      56. Laperche S, Boukatou G, Kouegnigan L, Nébié Y, Boulahi MO, Tagny CT, Yahaya R, Tapko JB, Murphy E, Lefrère JJ. Transfusion safety on the African continent: an international quality control of virus testing in blood banks. Transfusion. 2009 Aug; 49(8):1600-8.
        View in: PubMed
      57. Murphy EL, McFarland W, Lefrère JJ. Teaching transfusion medicine research methods in the developing world. Transfusion. 2009 Aug; 49(8):1532-4.
        View in: PubMed
      58. Halin M, Douceron E, Clerc I, Journo C, Ko NL, Landry S, Murphy EL, Gessain A, Lemasson I, Mesnard JM, Barbeau B, Mahieux R. Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription. Blood. 2009 Sep 17; 114(12):2427-38.
        View in: PubMed
      59. Murphy EL, Shaz B, Hillyer CD, Carey P, Custer BS, Hirschler N, Fang J, Schreiber GB. Minority and foreign-born representation among US blood donors: demographics and donation frequency for 2006. Transfusion. 2009 Oct; 49(10):2221-8.
        View in: PubMed
      60. Triulzi DJ, Kleinman S, Kakaiya RM, Busch MP, Norris PJ, Steele WR, Glynn SA, Hillyer CD, Carey P, Gottschall JL, Murphy EL, Rios JA, Ness PM, Wright DJ, Carrick D, Schreiber GB. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion. 2009 Sep; 49(9):1825-35.
        View in: PubMed
      61. DeVita DA, White MC, Zhao X, Kaidarova Z, Murphy EL. Determinants of subject visit participation in a prospective cohort study of HTLV infection. BMC Med Res Methodol. 2009; 9:19.
        View in: PubMed
      62. de Almeida Neto C, Murphy EL, McFarland W, Junior AM, Chen S, Chamone DA, Sabino EC. Profile of blood donors with serologic tests reactive for the presence of syphilis in São Paulo, Brazil. Transfusion. 2009 Feb; 49(2):330-6.
        View in: PubMed
      63. Custer B, Kamel H, Kiely NE, Murphy EL, Busch MP. Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening. Transfusion. 2009 Feb; 49(2):278-88.
        View in: PubMed
      64. Bartman MT, Kaidarova Z, Hirschkorn D, Sacher RA, Fridey J, Garratty G, Gibble J, Smith JW, Newman B, Yeo AE, Murphy EL. Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection. Blood. 2008 Nov 15; 112(10):3995-4002.
        View in: PubMed
      65. Sloss BL, Franckowiak RP, Murphy EL. Development of new microsatellite loci and multiplex reactions for muskellunge (Esox masquinongy). Mol Ecol Resour. 2008 Jul; 8(4):811-3.
        View in: PubMed
      66. Goncalez TT, Sabino EC, Chen S, Salles NA, Chamone DA, McFarland W, Murphy EL. Knowledge, attitudes and motivations among blood donors in São Paulo, Brazil. AIDS Behav. 2008 Jul; 12(4 Suppl):S39-47.
        View in: PubMed
      67. Guiltinan AM, Kaidarova Z, Custer B, Orland J, Strollo A, Cyrus S, Busch MP, Murphy EL. Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors. Am J Epidemiol. 2008 Mar 15; 167(6):743-50.
        View in: PubMed
      68. Nguyen DD, Devita DA, Hirschler NV, Murphy EL. Blood donor satisfaction and intention of future donation. Transfusion. 2008 Apr; 48(4):742-8.
        View in: PubMed
      69. Schlumpf KS, Glynn SA, Schreiber GB, Wright DJ, Randolph Steele W, Tu Y, Hermansen S, Higgins MJ, Garratty G, Murphy EL. Factors influencing donor return. Transfusion. 2008 Feb; 48(2):264-72.
        View in: PubMed
      70. Madden E, Murphy EL, Custer B. Modeling red cell procurement with both double-red-cell and whole-blood collection and the impact of European travel deferral on units available for transfusion. Transfusion. 2007 Nov; 47(11):2025-37.
        View in: PubMed
      71. Custer B, Chinn A, Hirschler NV, Busch MP, Murphy EL. The consequences of temporary deferral on future whole blood donation. Transfusion. 2007 Aug; 47(8):1514-23.
        View in: PubMed
      72. de Almeida Neto C, McFarland W, Murphy EL, Chen S, Nogueira FA, Mendrone A, Salles NA, Chamone DA, Sabino EC. Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria. Transfusion. 2007 Apr; 47(4):608-14.
        View in: PubMed
      73. Beilke MA, Traina-Dorge VL, Sirois M, Bhuiyan A, Murphy EL, Walls JM, Fagan R, Winsor EL, Kissinger PJ. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection. Clin Infect Dis. 2007 May 1; 44(9):1229-34.
        View in: PubMed
      74. Kwaan N, Lee TH, Chafets DM, Nass C, Newman B, Smith J, Garratty G, Murphy EL. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. J Infect Dis. 2006 Dec 1; 194(11):1557-64.
        View in: PubMed
      75. De Castro-Costa CM, Araújo AQ, Barreto MM, Takayanagui OM, Sohler MP, da Silva EL, de Paula SM, Ishak R, Ribas JG, Rovirosa LC, Carton H, Gotuzzo E, Hall WW, Montano S, Murphy EL, Oger J, Remondegui C, Taylor GP. Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retroviruses. 2006 Oct; 22(10):931-5.
        View in: PubMed
      76. Reich P, Roberts P, Laabs N, Chinn A, McEvoy P, Hirschler N, Murphy EL. A randomized trial of blood donor recruitment strategies. Transfusion. 2006 Jul; 46(7):1090-6.
        View in: PubMed
      77. Glynn SA, Schreiber GB, Murphy EL, Kessler D, Higgins M, Wright DJ, Mathew S, Tu Y, King M, Smith JW. Factors influencing the decision to donate: racial and ethnic comparisons. Transfusion. 2006 Jun; 46(6):980-90.
        View in: PubMed
      78. Barcellos NT, Fuchs SC, Mondini LG, Murphy EL. Human T lymphotropic virus type I/II infection: prevalence and risk factors in individuals testing for HIV in counseling centers from Southern Brazil. Sex Transm Dis. 2006 May; 33(5):302-6.
        View in: PubMed
      79. Busch MP, Glynn SA, Stramer SL, Orland J, Murphy EL, Wright DJ, Kleinman S. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors. Transfusion. 2006 Mar; 46(3):469-75.
        View in: PubMed
      80. Carneiro-Proietti AB, Catalan-Soares BC, Castro-Costa CM, Murphy EL, Sabino EC, Hisada M, Galvão-Castro B, Alcantara LC, Remondegui C, Verdonck K, Proietti FA. HTLV in the Americas: challenges and perspectives. Rev Panam Salud Publica. 2006 Jan; 19(1):44-53.
        View in: PubMed
      81. Gabet AS, Moulés V, Sibon D, Nass CC, Mortreux F, Mauclère P, Gessain A, Murphy EL, Wattel E. Endemic versus epidemic viral spreads display distinct patterns of HTLV-2b replication. Virology. 2006 Feb 5; 345(1):13-21.
        View in: PubMed
      82. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005 Sep 5; 24(39):6058-68.
        View in: PubMed
      83. Custer B, Johnson ES, Sullivan SD, Hazlet TK, Ramsey SD, Murphy EL, Busch MP. Community blood supply model: development of a new model to assess the safety, sufficiency, and cost of the blood supply. Med Decis Making. 2005 Sep-Oct; 25(5):571-82.
        View in: PubMed
      84. Roucoux DF, Wang B, Smith D, Nass CC, Smith J, Hutching ST, Newman B, Lee TH, Chafets DM, Murphy EL. A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II. J Infect Dis. 2005 May 1; 191(9):1490-7.
        View in: PubMed
      85. Murphy E, Jacobson S, Franchini G, Taylor GP, Hanchard B, Morgan O, Lairmore M. International Retrovirology Association brings together scientists and clinicians to bridge discoveries about human T-lymphotropic viruses from the laboratory to clinical trials. Retrovirology. 2005; 2:22.
        View in: PubMed
      86. Jarvis GA, Janoff EN, Cheng H, Devita D, Fasching C, McCulloch CE, Murphy EL. Human T lymphotropic virus type II infection and humoral responses to pneumococcal polysaccharide and tetanus toxoid vaccines. J Infect Dis. 2005 Apr 15; 191(8):1239-44.
        View in: PubMed
      87. Sanchez AM, Schreiber GB, Nass CC, Glynn S, Kessler D, Hirschler N, Fridey J, Bethel J, Murphy E, Busch MP. The impact of male-to-male sexual experience on risk profiles of blood donors. Transfusion. 2005 Mar; 45(3):404-13.
        View in: PubMed
      88. Lee TH, Chafets DM, Busch MP, Murphy EL. Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry. J Clin Virol. 2004 Dec; 31(4):275-82.
        View in: PubMed
      89. Custer B, Tomasulo PA, Murphy EL, Caglioti S, Harpool D, McEvoy P, Busch MP. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Transfusion. 2004 Nov; 44(11):1547-54.
        View in: PubMed
      90. Custer B, Johnson ES, Sullivan SD, Hazlet TK, Ramsey SD, Hirschler NV, Murphy EL, Busch MP. Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion. 2004 Oct; 44(10):1417-26.
        View in: PubMed
      91. Murphy EL, Lee TH, Chafets D, Nass CC, Wang B, Loughlin K, Smith D. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion. J Infect Dis. 2004 Aug 1; 190(3):504-10.
        View in: PubMed
      92. Roucoux DF, Murphy EL. The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev. 2004 Jul-Sep; 6(3):144-54.
        View in: PubMed
      93. Murphy EL, David Connor J, McEvoy P, Hirschler N, Busch MP, Roberts P, Nguyen KA, Reich P. Estimating blood donor loss due to the variant CJD travel deferral. Transfusion. 2004 May; 44(5):645-50.
        View in: PubMed
      94. Orland JR, Wang B, Wright DJ, Nass CC, Garratty G, Smith JW, Newman B, Smith DM, Murphy EL. Increased mortality associated with HTLV-II infection in blood donors: a prospective cohort study. Retrovirology. 2004; 1:4.
        View in: PubMed
      95. Murphy EL, Wang B, Sacher RA, Fridey J, Smith JW, Nass CC, Newman B, Ownby HE, Garratty G, Hutching ST, Schreiber GB. Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection. Emerg Infect Dis. 2004 Jan; 10(1):109-16.
        View in: PubMed
      96. Murphy EL, Grant RM, Kropp J, Oliveira A, Lee TH, Busch MP. Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients. J Acquir Immune Defic Syndr. 2003 Aug 15; 33(5):655-6.
        View in: PubMed
      97. Murphy EL, Ownby HE, Smith JW, Garratty G, Hutching ST, Wu Y, Ameti DI. Pulmonary function testing in HTLV-I and HTLV-II infected humans: a cohort study. BMC Pulm Med. 2003 Jul 28; 3:1.
        View in: PubMed
      98. Glynn SA, Busch MP, Schreiber GB, Murphy EL, Wright DJ, Tu Y, Kleinman SH. Effect of a national disaster on blood supply and safety: the September 11 experience. JAMA. 2003 May 7; 289(17):2246-53.
        View in: PubMed
      99. Asmuth DM, Kalish LA, Laycock ME, Murphy EL, Mohr BA, Lee TH, Gallarda J, Giachetti C, Dollard SC, van der Horst CM, Grant RM, Busch MP. Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infection. Transfusion. 2003 Apr; 43(4):451-8.
        View in: PubMed
      100. Schreiber GB, Glynn SA, Damesyn MA, Wright DJ, Tu Y, Dodd RY, Murphy EL. Lapsed donors: an untapped resource. Transfusion. 2003 Jan; 43(1):17-24.
        View in: PubMed
      101. Alvord WG, Drummond JE, Arthur LO, Biggar RJ, Goedert JJ, Levine PH, Murphy EL, Weiss SH, Blattner WA. A method for predicting individual HIV infection status in the absence of clinical information. AIDS Res Hum Retroviruses. 1988 Aug; 4(4):295-304.
        View in: PubMed
      102. Murphy EL, De Ceulaer K, Williams W, Clark JW, Saxinger C, Gibbs WN, Blattner WA. Lack of relation between human T-lymphotropic virus type I infection and systemic lupus erythematosus in Jamaica, West Indies. J Acquir Immune Defic Syndr. 1988; 1(1):18-22.
        View in: PubMed
      Edward's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP